✦ LIBER ✦

O-018 Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients

✍ Scribed by Santini, V.; Allione, B.; Lunghi, M.; Levis, A.; Poloni, A.; Angelucci, E.; Onida, F.; Terenzi, A.; Finelli, C.; Ferrero, D.

Book ID: 122816771
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 68 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/S0145-2126(13)70040-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of decitabine in the treatment

Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)

✍ P.W. Wijermans; B. Rüter; M.R. Baer; J.L. Slack; H.I. Saba; M. Lübbert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Chronic myelomonocytic leukemia (CMML) characterized by cytopenias, bone marrow and peripheral blood cell dysplasia is notoriously hard to treat. Recent reclassification of CMML as a myelodysplastic/myeloproliferative (MDS/MPS) disease rather than a myelodysplastic syndrome (MDS) by the World Health

P-301 Results of 5-azacitidine therapy i

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB

DNMT3A mutational analysis in primary my

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

✍ Abdel-Wahab, O; Pardanani, A; Rampal, R; Lasho, T L; Levine, R L; Tefferi, A 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Efficacy of a 3-day, low-dose treatment

Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting

✍ Lübbert, M; Bertz, H; Wäsch, R; Marks, R; Rüter, B; Claus, R; Finke, J 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

First-line therapy with fludarabine comp

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

✍ Eichhorst, B. F.; Busch, R.; Stilgenbauer, S.; Stauch, M.; Bergmann, M. A.; Ritg 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 324 KB